Actually, a potential association between PKC activation and Wnt5a expression was reported in human melanoma based on the observations that blocking the Wnt5a pathway using specific antibodies inhibited PKC activation, cell motility and invasion [15]. This evidence concerns the gene WNT5A and melanoma.